Critical Assessment of Pharmacokinetic Drug–Drug Interaction Potential of Tofacitinib, Baricitinib and Upadacitinib, the Three Approved Janus Kinase Inhibitors for Rheumatoid Arthritis Treatment
Vijayabhaskar Veeravalli, Ranjeet Prasad Dash, Jennifer A. Thomas, R. Jayachandra Babu, Lakshmi Mohan Vamsi Madgula, Nuggehally R. Srinivas
Topics & Concepts
TofacitinibMedicineJanus kinase inhibitorRheumatoid arthritisPharmacologyPharmacokineticsDrugJanus kinaseDrug interactionTherapeutic drug monitoringInternal medicineCytokineRheumatoid Arthritis Research and TherapiesPeripheral Neuropathies and Disorders